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Abstract: Two of bioactive natural products were founded in a brown alga, Sargassum 
fulvellum.  After isolation and purification, the molecular structures of these two products 
were investigated by NMR spectroscopy and GC-mass spectroscopy. The two compounds 
were identified to be 1-O-palmitoyl-2-O-oleoyl-3-O-(α-D-glucopyranosyl) –glycerol 
(POGG) and 1-O-myristoyl-2-O-oleoyl-3-O-(α-D-glucopyranosyl) – glycerol (MOGG) 
which were obtained from Sargassum fulvellum for the first time. POGG and MOGG showed 
fibrinolytic activity in the reaction system of pro-u-PA and plasminogen. 
Keywords:  fibrinolytic activity; NMR; glucopyranosyldiacylglycerol; structure 
determination; Sargassum fulvellum 
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1. Introduction 
 
Algae living in a unique marine environment are more and more important in drug development 
because they metabolize many rare compounds via unknown pathway [1]. A number of studies 
illustrated that algae were important resource of natural drug development. For examples, the red alga 
Sphaerococcus coronopifolius showed antibacterial activity [2]; the green alga Ulva lactuca contained 
an anti-inflammatory compound [3]. Portieria hornemannii (Lyngbye) P.C. Silva was found to be a 
novel source of cytotoxic penta halogenated monoterpene, halomon, which has been selected for 
preclinical drug development since this compound shows toxicity to brain, renal and colon tumor 
cell-lines and preliminary evaluations in vivo have been encouraging [4]. Ulva fasciata produced a 
novel sphingosine derivative which has antiviral activity in vivo [5]. A cytotoxic metabolite, 
stypoldione, which inhibited microtubule polymerization and thereby prevented mitotic spindle 
formation, has been isolated from tropical brown alga, Stypopodium zonale [6]. An iodinated novel 
nucleoside has been isolated from Hypnea valitiae, which is a potent and specific inhibitor of 
adenosine kinase. It can be used in the studies of adenosine receptors in a variety of systems, and in 
studies on nucleotide metabolism and regulation [7]. Sargassum carpophyllum from the South China 
Sea is the source of two new bioactive sterols. These sterols induced morphological abnormality in the 
plant pathogenic fungus Pyricularia oryzae; also exhibited cytotoxic activity against several cultured 
cancer cell lines [8]. There are many algae that can convert simple polyunsaturated fatty acids, such as 
arachidonic acids, into complex eicosanoids and related oxylipins [9]. This conversation is very 
important because derivatives of arachidonic acids play role in maintaining homeostasis in 
mammalian systems and aberrant production of metabolites of this class occurs in diseases such as 
psoriasis, asthma, arteriosclerosis, heart disease, ulcers and cancer [7].   
The perennial brown alga Sargassum fulvellum has a wide distribution in the East China Sea. A 
polysaccharide with antitumor activity from S. fulvellum was studied [10] in early time. Also, sulfated 
polysaccharides isolated from S. fulvellum were found to have antioxidant activity [11]. Kang et al. 
reported [12] that solvent extracts from S. fulvellum has antipyretic, analgesic, and anti-inflammatory 
activities in mice. 
Researchers have found a lot of compounds from algae including glycosphingolipids, 
glycoglycerolipids, polyphenol phosphate glycoside and steryl glycoside. Among them, 
glucosyldiacylglycerol has been reported to have a few biological effects, including significant 
fibrinolysis [13, 14], specific inhibition of tumor [15], and increased the cloning activation of 
phosphatidylserine decarboxylase in both the Bacillus subtilis null pss and psd mutants [16]. In this 
work, two of natural glucosyldiacylglycerol were isolated from a brown alga S. fulvellum using 
repeated chromatography with an open column of silica gel, and their structures and biological 
activities were investigated.   
 
2. Results and discussion 
 
S. fulvellum was selected by a screening of approximately 700 of plant extracts for compounds that 
enhance reciprocal activation of pro-u-PA and plasminogen. Specimen of S. fulvellum was collected 
from the East Sea in China and dried in natural environment. The dried samples were extracted by the Mar. Drugs 2009, 7                                        
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mixture of methanol and chloroform. After removing the organic solvent, the residual was redissolved 
in chloroform and precipitated by the addition of acetone. The precipitate showing fibrinolytic activity 
was fractionated by repeated chromatography with an open column of silica gel and eluted with 
methanol and chloroform (proportion=3:7), to give compound 1 and compound 2. The yields of 
compound 1 and compound 2 from 200 g of brown alga were 25 mg and 15 mg, respectively.   
 
Scheme 1. Structures of compound 1 and 2. 
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The compound 1 was colorless. Its infrared spectrum presented characteristic absorption bands at 
2920 cm
-1, 2852 cm
-1, 1742 cm
-1, 1219 cm
-1, 1171 cm
-1, 1035 cm
-1, and 771cm
-1. The positive-ion fast 
atom bombardment mass of the compound 1 gave the molecular weight with sodium ion at m/z 779 
[M+Na]
+ and fragment ions at 594 [M-163 (hexose moiety)+H]
+, 256 [M-501 (163: hexose moiety, 
281: oleoyl moiety, 57: glycerol moiety)+H]
+, 282 [M-475 (163: hexose moiety, 255: palmitoyl moiety, 
57: glycerol moiety) +H]
+ by an assistant of trimethanolamine (Fig. 1). Using a negative-ion fast atom 
bombardment mode, other fragment ions were found at 162 [M-593 (281: oleoyl moiety, 255: 
palmitoyl moiety, 57: glycerol moiety)-H]
-. These fragment ions suggested the molecule of this 
compound contains three parts, hexose unit and two fatty acyl moieties from single dimensional 
spectrum. The molecular formula was deduced to be C43H80O10 based on the fast atom bombardment 
masses, 
13C and 
1H NMR spectra. 
 
Figure 1. The molecular weight and fragment of compound 1.The molecular weight of 
compound 1 was m/z 779 with sodium ion and the fragments were m/z 593, 281, 255 and 
162. 
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The existence of  two fatty acid residues in the molecular structure of compound 1 were also 
identified from the wrap over 
1H and 
13C NMR signals in the range of 1.23~1.30 and 28.30~28.97 
respectively. Methanolysis of the compound 1 yielded two methylated fatty acid, methyl palmitate and 
methyl oleate, which were identified by comparing the GC-MS results with those of authentic 
standards [17]. 
To further understand the molecular structure of compound 1, Table 1 gives the assignments of 
methine, methylene, methyl and quaternary carbon resonances obtained from 
13C spectrum and 
13C 
DEPT spectrum (90 and 135). The chemical shifts of methine carbons in the sugar moiety appeared 
at 98.3 ppm, 71.6 ppm, 72.8 ppm, 74.4 ppm, 68.4 ppm and 54.9 ppm in 
13C spectrum which could be 
assigned to C-1’’’, C-2’’’, C-3’’’, C-4’’’, C-5’’’, and C-6’’’, respectively.  The spectral assignment 
of carbon resonances and proton resonances in methine of hexose was decided from HMQC (table 1) 
spectrum. In the 
1H spectrum, the signal of the anomeric proton in the sugar moiety appeared at 4.56 
(d, J = 3.7), which showed a 1, 2-diequatorial relationship and indicated that the sugar moiety was 
-configuration at C1 [18, 19]. The two dimensional correlation of the adjoining proton resonances 
was investigated by 
1H-
1H COSY. The correlation of neighbouring C-ring protons in hexose was 
found by corresponding cross peaks in the 
1H-
1H COSY spectrum (fig. 2). 
1H NMR coupling 
constants and 
13C NMR chemical shifts suggested that the hexose was glucose, and its J1’”, 2”’ (3.7 Hz, 
diaxial), J2’”, 3’” (9.2 Hz, diaxial), J3’”, 4’” (9.2 Hz, diaxial), and J4’”, 5’”   (9.6 Hz, diaxial) values in the 
1H 
NMR spectrum proposed that the hexose of compound 1 should be -D-glucopyranosyl [20]. The 
structure of glucose was further confirmed by the cross peaks of H-1”’ (δH 4.56)/H-2”’ (δH 3.18), 
H-2”’/H-3”’ (δH 3.36), H-3”’/H-4”’ (δH 2.94), H-4”’/H-5”’ (δH 3.78), H-5”’/H-6”’ (δH 2.58, 2.57) in 
1H-
1H COSY spectrum.   
 
Table 1. The 
1H and 
13C NMR data of compound 1 from Sargassum fulvellum. 
 
No. δC δH
1 62.5 4.34 (1H, dd, J = 2.6, 12.1), 4.21 (1H, dd, J = 2.6, 12.1)
2 69.7 5.12 (1H, m)
3 64.7 3.87 (1H, dd, J = 5.8, 10.6), 3.41 (1H, dd, J1=5.5, 10.6)
1"' 98.3 4.56 (1H, d, J = 3.7)
2"' 71.6 3.18 (1H, dd, J = 4.4, 9.2)
3"' 72.8 3.36 (1H, t, J = 9.2)
4"' 74.4 2.94 (1H, t, J = 9.2)
5"' 68.4 3.78 (1H, ddd, J = 5.1, 5.5, 9.5)
6"' 54.9 2.58 (1H, dd, J = 4.8, 13.9), 2.57 (1H, dd, J = 6.2, 13.9) 
1', 1" 172.4, 172.2
2', 2" 33.5, 33.3 2.26 (4H, m)
3', 3" 24.3 1.49 (4H, m)
4' - 7', 12' - 15', 4" - 13" 28.3 - 28.9 1.2 - 1.3 (m)
8', 11' 26.5, 26.4 1.97 (4H,m)
9', 10' 129.5, 129.4 5.04 (2H, t, J = 4.8)
16', 14" 31.2 1.2 - 1.3 (m)
17', 15" 21.9 1.2 - 1.3 (m)
18', 16" 13.7 0.84 (6H, t, J = 6.8)
The chemival shift is relative to DMSO - d 6 (δC 39.5 ppm; δH 2.49 ppm).
The coupling constant (J) is given in Hz.
The assignments of the two fatty acyl moieties are tentative and concomitantly interchangeable.  Mar. Drugs 2009, 7                                        
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C-1, C-2, and C-3 were attributed to glycerol moiety, which were also deduced from two 
dimensional resonances of HMQC and 
1H-
1H COSY. The signals of C-1, C-2, and C-3 in single 
dimension carbon spectrum on middle field has coupling proton signals of 4.34 ppm (C-1), 4.21 ppm 
(C-1), 5.12 ppm (C-2), 3.87 ppm (C-3), and 3.41 ppm (C-3), respectively. The protons were 
acknowledged to adjoining oxygen atom because of its high magnetic field.   
The glycosidic linkage between the glucose and glycerol was determined by glycosidation shift in 
13C-NMR and HMBC spectra, the chemical shift of C-1’’’ in glucose unit was at 98.3. Its proton was 
obviously correlated with the signal of C-3 in HMBC spectrum. In HMBC spectrum, two correlations 
were observed between the proton signal at δ4.21 (dd, J = 2.6, 12.1) or δ5.12 and the quaternary 
carbon signal at δ172.2 or δ172.4, suggesting the glycerol moiety was attached to C-1’ or C-1” of the 
fatty moiety. The carbons and protons resonances of fatty residue moieties possess correlation, 
resulting in many cross peaks in 
1H-
1H COSY (Fig. 2) and HMBC spectrum (Fig. 3).   
 
Figure 2. The 
1H-
1H COSY spectrum of the compound in DMSO-d6. 
 
 
 
Figure 3. Important HMBC correlation for compound 1. 
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In the spectrum of positive-ion fast atom bombardment mass, palmitoyl moiety of ion peak at m/z 
256 was most notable at 100% of fragment strength, suggesting it was strongly bombarded by 
electronic flow due to weak electronic shielding effect. Therefore, palmitoyl moiety was determined 
at C-1 because the electronic shielding role of C-1 was weaker than those of C-2 and C-3 as shown in 
the 
13C spectrum. Further, the oleoyl moiety was speculated at C-2. 
Based on the above analysis of NMR data and mass spectra, the structure of the compound 1 was 
established to be 1 – O – palmitoyl – 2 – O – oleoyl – 3 – O – ( - D – glucopyranosyl) – glycerol 
(POGG).          
The pure compound 2 was also colorless. Its rate of flow (Rf = 0.30) was smaller than that of 
compound 1 (Rf = 0.48) when it was eluted using chloroform and MeOH (proportion=3:7) including 
1% of acetic acid (V/V). Its characteristic absorption bands in infrared spectrum were similar to 
compound 1. The positive-ion fast atom bombardment mass of the compound 2 gave the molecular 
weight with sodium ion at m/z 718 [M+Na]
 + and mainly fragment ions at 212, which was identified 
to be myristoyl moiety by GC-MS. Table 2 presents the NMR data for compound 2 . By the similar 
analysis as compound 1,   the compound 2 was determinated to be 1 – O – myristoyl – 2 – O – 
oleoyl – 3 – ( - D – glucopyranosyl) – glycerol (MOGG).   
 
Table 2. The 
1H and 
13C NMR data of compound 2 from Sargassum fulvellum. 
 
No. δC                  δH
1 62.6 4.09 (1H, dd, J = 7.4, 11.4),  4.30 (1H, d, J = 11.8)
2 69.7 5.10 (1H, d, J = 5.0)
3 64.6 3.36 (1H, dd, J = 5.9, 10.3), 3.85(1H, dd, J = 5.8, 10.5)
1"' 98.3 4.54 (1H, d, J = 3.5)
2"' 71.6 3.15 (1H, m)
3"' 72.9 3.32 (1H, t, J = 8.9)
4"' 74.2 2.88 (1H, m)
5"' 68.5 3.74 (1H, m)
6"' 54.5 2.52 (1H, dd, J = 6.8, 12.5), 2.88 (1H, m)
1', 1" 172.3, 172.4
2', 2" 33.4, 33.6 2.22 (2H, t, J = 7.1), 2.26(2H, m)
3', 3" 24.4 1.46 (4H, dd, J = 6.7, 13.4)
4" - 7" 28.4-29.1 1.2 - 1.3 (m)
8", 11" 26.5, 26.6 1.2 - 1.3 (m), 1.94 (2H, m)
9", 10" 129.4, 129.5 5.27 (1H, t, J = 4.5), 5.35 (1H, d, J = 2.5)
12" - 15" 28.4-29.1 1.2 - 1.3 (m)
4' - 11' 28.4-29.1 1.2 - 1.3 (m)
16", 12' 31.3 1.2 - 1.3 (m)
17", 13' 22.1 1.2 - 1.3 (m)
18", 14' 13.9 0.81 (6H, t, J = 6.7)
The chemical shift is relative to DMSO-d 6 (δC=39.5 ppm; δH=2.49 ppm).
The coupling constant (J) is given in Hz.
The assignments of tow fatty acyl material are tentative and concomitantly interchangeable.  Mar. Drugs 2009, 7                                        
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The fibrinolytic activities of compound 1 and 2 were investigated by the reciprocal activation of 
single chain urokinase-type plasminogen activator (pro-u-PA) and plasminogen. The addition of 
POGG (0.66-15.9 μM) or MOGG (0.66-5.28 μM) shortened the initiation time of pro-u-PA activation 
and increased the rate of activation in vitro (Fig. 4A, 4C), respectively. The dose-response curves 
were hyperbolic, and half-maximal effect were obtained approximately at 0.85μM of POGG (Fig. 4 B) 
and 1.3 μM (Fig. 4 D). These results illustrated that POGG and MOGG showed fibrinolytic activity in 
the reaction system of pro-u-PA and plasminogen, and MOGG exhibited weaker fibrinolytic activity 
than POGG. 
 
Figure 4. Effect of POGG and MOGG on reciprocal activation of pro-u-PA and plasminogen. 
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Pro-u-PA and plasminogen were incubated with the indicated concentrations of POGG and MOGG 
in the presence of Spectrozyme UK to determine reciprocal activation of pro-u-PA. Time course of 
the POGG and MOGG effect is shown in A, C and dose-response curve in B, D, respectively, in 
which the index for fibrinolytic activation is given in ordinate as percent of control value. 
 
3. Conclusions 
 
In this work, two of glucopyranosyldiacylglycerols, POGG and MOGG were isolated from the Mar. Drugs 2009, 7                                        
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brown alga S. fulvellum, and there molecular structures were determined by NMR spectroscopy and 
mass spectroscopy. The extracts of S. fulvellum have been reported to have many biological roles, 
including antipyretic, analgesic, anti-inflammatory [12], antitumor [10] and antioxidant [11]. 
According to our knowledge, this is the first time to isolate MOGG from marine lives and discover 
that POGG and MOGG enhanced reciprocal activation of pro-u-PA and plasminogen in vitro. 
 
4. Experimental section 
 
4.1 General experimental procedures 
 
Fast atom bombardment mass were determined with an assistant of trimethanolamine on a 
SX-102A mass spectrometer (JEOL USA Inc.). The infrared spectra were measured on a 
JIR-WINSPEC 50 FT-IR spectrometer (JEOL, Tokyo, Japan). 
1H-NMR (600 MHz), 
13C-NMR (150 
MHz), and DEPT spectra were recorded on a JNM alpha 600 FT NMR spectrometer (JEOL, Tokyo, 
Japan) in dimethylsolfate-d6 (DMSO-d6), and chemical shifts are given in the  (ppm) scale, with 
coupling constants (J) in Hz with tetramethylsilane as a contrast standard. Procoated Kieselgel 60 F254 
cards (thickness 0.2 mm, Merck, Germany, No. 5450) were used to analysis of purification for thin 
layer chromatography using the solvent system of chloroform-methanol-acetic acid. Spot detection 
was conducted by spraying iodine vapor at room temperature. 
The heteronuclear multiple quantum coherence (HMQC) experiment was carried out at 600.05 
MHz with a sweep width of 4168.0 Hz and 2995.8 Hz. A 1.2-seconds relaxation delay was used and 
64 transients were performed for each t1 value.   
The 
1H-
1H correlation spectroscopy experiment was carried out at 600.05 MHz with a sweep width 
of 4164.3 Hz and 2989.5 Hz. A 0.83-second relaxation delay was used and 16 transients were 
accumulated for each t1 value. 
The 
1H detected multiple bound connectivity experiment was carried out at 600.05 Hz with a 
sweep width of 4165.4 and 2995.8 Hz in F1 and F2, respectively. The data set 512 points, and the 
mixing time 60 msec. The spectrum was recorded in the absorption mode.   
 
4.2 Isolation of biophysiological substance   
 
The compounds were extracted with chloroform-methanol (2:1) from S. fulvellum and isolated by 
repeated chromatography with silica gel columns. Briefly, dried S. fulvellum (200 g) was extracted 
twice with 900 ml of chloroform-methanol (2:1) and once with 900 ml of chloroform-methanol (1 : 2), 
and the organic extracts was evaporated to dryness, giving 15.1 g of oily residue. The residue was 
redissolved in 15.1 ml of chloroform, followed by the addition of 300 ml of acetone. The precipitate 
was collected by centrifugation. The precipitate (500 mg) was further fractionated by repeated 
chromatography with silica gel columns using solvent systems of chloroform-methanol and 
chloroform-methanol containing 1% acetic acid. Active component (15.1 mg) was recovered in a 
chloroform fraction in the final step.     Mar. Drugs 2009, 7                                        
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4.3 Methanolysis of the compound 
 
The compound 1 (3 mg) were dissolved in 1.5 ml of methanol solution (82%) containing 0.9 N of 
HCl. The solution was heated to 70￿ for 18 hours [21, 22]. Then the solvent was evaporated to 0.1 ml 
under reduced pressure at 40￿, followed by the extraction with hexane to yield an organic layer, 
which was purified using silica gel chromatography with elution of chloroform. The sample was 
dissolved in methanol for analysis by a JMS-GC Mate II (JEOL, Peabody, MA). A silica capillary GC 
column (30m 0.25mm, Agilent Technologies, Inc.) was used, and the column oven temperature was 
kept at 80 °C for 1 min after sample injection and then increased at a rate of 32￿ per min up to 150￿, 
subsequently at a rate of 4￿ per min up to 250￿, the flow rate of helium carrier gas was 1 ml/min. 
Identification of the peaks was accomplished by comparing the relative retention time and the mass 
spectra with those of standard fatty methyl esters. 
 
4.4 Analysis of fibrinolytic activity 
 
The fibrinolytic activities were determined in 50 μl of TBS/BSA (50 mM Tris-HCl, 100 mM NaCl 
and 2 mg/ml bovine serum albumin, pH 7.4) at 37℃ using a round-bottomed 96-well plate. The 
release of p-nitoaniline was measured serially for up to 120 min at 405 nm. The concentrations of 
pro-u-PA, plasminogen and Spectrozyme UK were as 20 nM, 5 nM and 100 μM, respectively.   
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